Latest news
Apogee Therapeutics (APGE) details Q2 2026 losses, AbbVie merger plan and $100M BXLS deal - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 11:53:11 GMTApogee's Atopic Dermatitis Drug Shows 65.9% EASI-75 - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 11:00:00 GMTREGENXBIO (Nasdaq: RGNX) turns Q2 profit on $100M AbbVie milestone - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 11:10:36 GMTFDA approves Ironwood's LINZESS for functional constipation in children 2+ - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 11:05:00 GMTIf Approved, Botox Would Be First and Only Neurotoxin for Masseter Prominence - stocktitan.netstocktitan.net · Tue, 04 Aug 2026 12:00:00 GMTAbbVie (NYSE: ABBV) lifts 2026 revenue to 31,992 million - stocktitan.netstocktitan.net · Mon, 03 Aug 2026 18:14:35 GMTAbbVie (NYSE: ABBV) boosts Q2 profit, plans $10.9B Apogee acquisition - stocktitan.netstocktitan.net · Fri, 31 Jul 2026 11:51:57 GMTJUVÉDERM marks 20 years since FDA approval with buy-one-get-one $75 cards - stocktitan.netstocktitan.net · Thu, 30 Jul 2026 12:00:00 GMT